McCall McPhersonFounder, Modern Thyroid Clinic.

Reduce your biggest health risk by 20%? Yes please!

5 Aug 2024 · 1 min

Watch on YouTube

1:01

Short YouTube monologue by McCall McPherson about semaglutide (Wegovy). The speaker cites a New England Journal of Medicine study and states that semaglutide showed an approximately 20% reduction in heart attack and stroke (heart disease) risk; she also notes the UK approved Wegovy for a heart-disease prevention study and frames these drugs as having impacts beyond weight loss. The clip ends with a call to share and comment.

Questions this video answers

Approximately 20% reduction in heart attack and stroke risk.

The New England Journal of Medicine.

The UK approved Wegovy (semaglutide) for a heart disease prevention study.

Chapters

What if I told you you could Prevent the number one cause of death by 20% that is heart disease. That's heart attack and stroke. It kills more people every year than all forms of cancer combined. I want you to say that sentence again in your mind again because powerful, powerful, powerful. This week the UK approved WeGovy aka Semaglutide for heart disease prevention study. The study in the New England Journal of Medicine, which is literally the best journal out there for medicine showed a risk reduction of heart attack stroke by 20% for people on WEGOV or semaglutide. These meds are changing everything guys. This is not about weight loss anymore. Just watch the unraveling of all the things that these medications impact because I'll keep sharing them with you but they're more and more almost every day. Share this with a friend that you feel like would benefit from this. Post your comments below or questions and let's talk about it.